These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30471171)

  • 21. Potent inhibitors of 5-lipoxygenase identified using pseudoreceptors.
    Rödl CB; Tanrikulu Y; Wisniewska JM; Proschak E; Schneider G; Steinhilber D; Hofmann B
    ChemMedChem; 2011 Jun; 6(6):1001-5. PubMed ID: 21506275
    [No Abstract]   [Full Text] [Related]  

  • 22. Geldanamycin-induced PCNA degradation in isolated Hsp90 complex from cancer cells.
    Wang X; Heuvelman DM; Carroll JA; Dufield DR; Masferrer JL
    Cancer Invest; 2010 Jul; 28(6):635-41. PubMed ID: 20394503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-terminal heat shock protein 90 modulators produce desirable oncogenic properties.
    Wang Y; McAlpine SR
    Org Biomol Chem; 2015 Apr; 13(16):4627-31. PubMed ID: 25711919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of a novel class Hsp90 inhibitors containing 1-phenylpiperazine scaffold.
    Jia JM; Liu F; Xu XL; Guo XK; Jiang F; Cherfaoui B; Sun HP; You QD
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1557-61. PubMed ID: 24582477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of TNF-alpha and inhibitors of arachidonic acid metabolism on human colon HT-29 cells depend on differentiation status.
    Kovaríková M; Hofmanová J; Soucek K; Kozubík A
    Differentiation; 2004 Feb; 72(1):23-31. PubMed ID: 15008823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90.
    Kelland LR; Sharp SY; Rogers PM; Myers TG; Workman P
    J Natl Cancer Inst; 1999 Nov; 91(22):1940-9. PubMed ID: 10564678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Redefining the Phenotype of Heat Shock Protein 90 (Hsp90) Inhibitors.
    Wang Y; Koay YC; McAlpine SR
    Chemistry; 2017 Feb; 23(9):2010-2013. PubMed ID: 27862436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid-phase immunoassays in mechanism-based drug discovery: their application in the development of inhibitors of the molecular chaperone heat-shock protein 90.
    Hardcastle A; Boxall K; Richards J; Tomlin P; Sharp S; Clarke P; Workman P; Aherne W
    Assay Drug Dev Technol; 2005 Jun; 3(3):273-85. PubMed ID: 15971989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological cross-reactivity between 5-lipoxygenase-activating protein, 5-lipoxygenase, and leukotriene C4 synthase.
    Gupta N; Nicholson DW; Ford-Hutchinson AW
    Can J Physiol Pharmacol; 1997; 75(10-11):1212-9. PubMed ID: 9431445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Hydroxycinnamic Acid Esters as Novel 5-Lipoxygenase Inhibitors That Affect Leukotriene Biosynthesis.
    Boudreau LH; Lassalle-Claux G; Cormier M; Blanchard S; Doucet MS; Surette ME; Touaibia M
    Mediators Inflamm; 2017; 2017():6904634. PubMed ID: 28680195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Lipoxygenase inhibitors: a review of recent patents (2010-2012).
    Hofmann B; Steinhilber D
    Expert Opin Ther Pat; 2013 Jul; 23(7):895-909. PubMed ID: 23600432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myxochelin-Inspired 5-Lipoxygenase Inhibitors: Synthesis and Biological Evaluation.
    Schieferdecker S; König S; Pace S; Werz O; Nett M
    ChemMedChem; 2017 Jan; 12(1):23-27. PubMed ID: 27875023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.
    Armstrong HK; Koay YC; Irani S; Das R; Nassar ZD; ; Selth LA; Centenera MM; McAlpine SR; Butler LM
    Prostate; 2016 Dec; 76(16):1546-1559. PubMed ID: 27526951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of 2-amino-6-(1H,3H-benzo[de]isochromen-6-yl)-1,3,5-triazines as novel Hsp90 inhibitors.
    Suda A; Kawasaki K; Komiyama S; Isshiki Y; Yoon DO; Kim SJ; Na YJ; Hasegawa K; Fukami TA; Sato S; Miura T; Ono N; Yamazaki T; Saitoh R; Shimma N; Shiratori Y; Tsukuda T
    Bioorg Med Chem; 2014 Jan; 22(2):892-905. PubMed ID: 24369839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How Selective are Hsp90 Inhibitors for Cancer Cells over Normal Cells?
    Wang Y; Koay YC; McAlpine SR
    ChemMedChem; 2017 Mar; 12(5):353-357. PubMed ID: 28139075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 90-kDa heat shock protein inhibition abrogates the topoisomerase I poison-induced G2/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1.
    Tse AN; Sheikh TN; Alan H; Chou TC; Schwartz GK
    Mol Pharmacol; 2009 Jan; 75(1):124-33. PubMed ID: 18820127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-Substituted pyrazole-3-carboxamides as inhibitors of human 15-lipoxygenase.
    Pelcman B; Sanin A; Nilsson P; Schaal W; Olofsson K; Krog-Jensen C; Forsell P; Hallberg A; Larhed M; Boesen T; Kromann H; Claesson HE
    Bioorg Med Chem Lett; 2015 Aug; 25(15):3017-23. PubMed ID: 26037319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of 5-lipoxygenase inhibition on blood-brain barrier permeability in experimental brain tumors.
    Baba T; Chio CC; Black KL
    J Neurosurg; 1992 Sep; 77(3):403-6. PubMed ID: 1354721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stability.
    Delorme D; Ducharme Y; Brideau C; Chan CC; Chauret N; Desmarais S; Dubé D; Falgueyret JP; Fortin R; Guay J; Hamel P; Jones TR; Lépine C; Li C; McAuliffe M; McFarlane CS; Nicoll-Griffith DA; Riendeau D; Yergey JA; Girard Y
    J Med Chem; 1996 Sep; 39(20):3951-70. PubMed ID: 8831761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.